TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
2.970
+0.040 (1.37%)
At close: Dec 20, 2024, 4:00 PM
3.040
+0.070 (2.36%)
After-hours: Dec 20, 2024, 4:37 PM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $167.82 million as of December 20, 2024. Its market cap has decreased by -47.63% in one year.
Market Cap
167.82M
Enterprise Value
-12.94M
1-Year Change
-47.63%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $167.82M, a decrease of -53.26%. That is a compound annual growth rate of -19.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 167.82M | -39.81% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrainsWay | 173.14M |
| Kyverna Therapeutics | 172.69M |
| Nektar Therapeutics | 171.23M |
| Lyell Immunopharma | 171.08M |
| scPharmaceuticals | 169.64M |
| Elutia | 167.28M |
| Nkarta | 167.25M |
| Solid Biosciences | 166.21M |